Unblinded: A Clinical Trial Podcast
Veeva Systems
Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Unblinded: A Clinical Trial Podcast (formerly The State of Digital Clinical Trials) is a Veeva podcast hosted by Manny Vazquez, Senior Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of clinical trials.
Explore Statistics
Recent Episodes
Deep Pockets, Short Arms: Is MedTech Ready for AI?
In this episode of Unblinded, host Manny Vazquez is joined by Leianne Ebert, Head of Data Operations at Alcon, and co-host John Acampado, Senior Director of Clinical Strategy for Veeva MedTech.…
The Economics of Clinical Trial Outsourcing
Joel White, owner of Marketcap Consulting, together with Veeva’s Chris Kreitel, joins Manny to discuss why the next era of clinical trial outsourcing will be defined by technology integration and…
A People-Focused Approach to a Risk-Based Future in Clinical Trials
In this episode, host Manny Vazquez is joined by Noeleen Turner, head of clinical data management at UCB, and Anna Hayes, senior director of clinical data management at Veramed. Using their breadth…
ICH E6(R3): Shifting the Paradigm from Process to Purpose
In this episode, we pull back the curtain on the monumental effort required to reshape global clinical trial standards. Manny and guests Lisbeth Bregnhoj and Cheryl Grandinetti explore why ICH E6(R3)…
The Unstuck Industry: A New Equitable Model for Pharma
Brian Johnson, former head of R&D technology at Takeda, now consultant, shares his unique perspective on a topic that’s top-of-mind for many: how do you introduce new technologies and processes…
S4E4 Innovation from the Inside: How Sites Are Redefining Clinical Research
Manny is joined by co-host Denali Rose and MSKCC’s Joe Lengfellner, to discuss the shifting focus from a one-size-fits-all approach to redefine site centricity. They talk about how the role of a…
S4E2 Patient vs. Process: Bridging the Gap for a Better Trial Experience
Join host Manny Vazquez as he sits down with Joyce Moore, leading voice in patient recruitment with over 25 years of experience in the industry, most recently at Allucent. In a field often focused on…
Biggest Risks (and Possible Rewards) of AI in Clinical Data
Are we any closer to working out the human-machine relationship needed to embed AI in clinical development? To discuss this and all things automation, Veeva’s Chief Technology Officer Drew Garty…
S3E6 The State of Patient Engagement: From a Patient Advocate
Manny Vazquez (our new host) interviews Trishna Bharadia, a patient engagement consultant and advocate. Since receiving a life-changing diagnosis 15 years ago, Trishna has made it her mission to…
S3E5 Is a Heavy Tech Burden the Price of Progress for Sites?
Richard Young passes the torch to Manny Vazquez, our new podcast host, and shares his reflections before turning off his mic for the final time. Later, Manny is joined by renowned industry thinker…
S3E4 AI and Clinical Transformation: High-Value or Hype?
Novo Nordisk’s Vice President for Clinical Data Operations and Insights Ibrahim Kamstrup-Akkaoui joins Richard this week for episode 4 of Season 3. As Ibrahim explains, the pace of innovation in…
S3E3 Does Data Science Require Data Perfection?
Pfizer’s Vice President for Data Monitoring and Management Demetris Zambas joins Richard in the hot seat and shares his fascinating journey through life sciences: from how his childhood experiences…
S3E2 The Launch of Boehringer Ingelheim’s One Medicine Program
Nicole Raleigh hosts this special episode on-site from Boehringer Ingelheim’s Human Pharmacology Center in Biberach, Germany. Andrea Kloeble and Daniel Schwenk are part of the team reimagining drug…
S3E1 Against All Odds: Finding a Treatment for SPG50
We can think of no better way to kick off Season 3. In a deeply personal and moving episode, two patient advocates share their stories of working tirelessly to deliver a safe and effective gene…
S2E9 Are We Too Risk Averse in Clinical Research?
This week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development. Already well-known in our industry for his pioneering…
Putting Patient Data at the Heart of Your Strategy
In this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect novel insights from large volumes of…
Does Patient Choice Equal Site Headaches?
The first episode of Season 2 is now out! This week, Richard Young speaks to Helen Shaw, co-founder and director of clinical operations at VCTC (a virtual site) and Marie-Claire Flavin, who joined…
S2E7 Sites Are Voicing Their Concerns, But Are We Listening?
In this week’s episode, Richard Young speaks to Vivienne van de Walle, medical director and founder of PT&R (an independent research site in the Netherlands), and Bree Burks, who joined @Veeva…
S2E6 Transforming Clinical Operations: What Comes Next?
In this episode, Richard Young speaks with Bayer’s Head of Clinical Trial Management Services and Solutions, Emma Earl. With over 20 years of experience, Emma is perfectly positioned to comment on…
S2E5 The State of Clinical Trials in the U.K. and Europe
Host: Nicole Raleigh, Web Editor, Pharmaphorum Guest: Chris Moore, President, Veeva Europe We have a special episode for you this week! In a twist to our usual format, Nicole Raleigh of…
Frequently Asked Questions
Unblinded: A Clinical Trial Podcast has published 33 episodes since July 2022, covering topics in Life Sciences, Science.
Unblinded: A Clinical Trial Podcast is currently active with new episodes monthly. Average episode length is 32m.
Sign up on Grep.FM to access contact details for Unblinded: A Clinical Trial Podcast, including email and social media links.
